Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | 0.00% | +5.02% | -14.67% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Business Summary
Number of employees: 217
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Lung Diagnostic
91.9
%
| 29 | 76.7 % | 45 | 91.9 % | +54.05% |
Biopharma Services and Other
7.9
%
| 4 | 9.6 % | 4 | 7.9 % | +6.02% |
COVID-19
0.1
%
| 5 | 13.7 % | 0 | 0.1 % | -98.91% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 38 | 100.0 % | 49 | 100.0 % | +28.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | 14-12-31 | |
Comptroller/Controller/Auditor | 50 | 21-02-01 | |
Kieran O’Kane
PRN | Corporate Officer/Principal | 47 | 18-01-31 |
Gary Pestano
PRN | Corporate Officer/Principal | 57 | 12-02-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Hany Massarany
BRD | Director/Board Member | 62 | 20-07-19 |
Matthew Strobeck
BRD | Director/Board Member | 51 | 11-12-31 |
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Jean Franchi
BRD | Director/Board Member | 57 | 20-03-31 |
Charles Watts
BRD | Director/Board Member | 81 | 19-06-30 |
Lawrence Kennedy
BRD | Director/Board Member | 52 | 23-01-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 114,685,783 | 44,522,718 ( 38.82 %) | 0 | 38.82 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.67% | 178M | |
-23.35% | 8.54B | |
+67.47% | 4.32B | |
-0.82% | 2.53B | |
-39.22% | 2.48B | |
-8.65% | 1.9B | |
-17.46% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M |
- Stock Market
- Equities
- BDSX Stock
- Company Biodesix, Inc.